← Back
Data updated: Mar 10, 2026
FACTA FARMA
Infectious DiseaseDermatology
FACTA FARMA is a generic drug manufacturer focused on Infectious Disease, Dermatology. Key products include CEFAZOLIN SODIUM.
1978
Since
4
Drugs
-
Trials
15
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CEFAZOLIN SODIUM 2026-02-13
Efficacy
CEFAZOLIN SODIUM 2025-12-01
Manufacturing (CMC)
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEFAZOLIN SODIUM 2025-08-21
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2025-05-07
Labeling
CEPHALEXIN 2024-12-23
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 67%
2 drugs
Dermatology 33%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 1978-03-27
- Latest
- 2016-06-24
- Applications
- 8